Larina I I, Makazan N V, Ivashchenko K V, Platonova N M, Orlova E M, Kareva M A, Sozaeva L S, Yukina M Yu, Tulpakov A N, Dukhanin A S, Shimanovskii N L, Troshina E A
Endocrinology Research Centre.
Research Centre for Medical Genetics.
Probl Endokrinol (Mosk). 2024 Feb 28;70(1):30-37. doi: 10.14341/probl13321.
Primary glucocorticoid resistance (OMIM 615962) is a rare endocrinologic condition caused by resistance of the human glucocorticoid receptor (hGR) to glucocorticoids (GR) and characterised by general or partial insensitivity of target organs to GK. Compensatory activation of hypothalamic-pituitary-andrenal axis results in development of a various pathological conditions caused by overstimulation of adrenal glands. Clinical spectrum may range from asymptomatic cases to severe cases of mineralocorticoid and/or androgen excess. At present time, primary generalized glucocorticoid resistance has been exclusively associated with defects in the NR3C1 gene. Here, we present a case report of an adolescent patient with clinical presentation of glucocorticoid resistance confirmed by detailed endocrinologic evaluation but no confirmed mutations in the NR3C1 gene.
原发性糖皮质激素抵抗(OMIM 615962)是一种罕见的内分泌疾病,由人类糖皮质激素受体(hGR)对糖皮质激素(GR)产生抵抗引起,其特征是靶器官对糖皮质激素普遍或部分不敏感。下丘脑-垂体-肾上腺轴的代偿性激活导致肾上腺过度刺激引发各种病理状况。临床症状范围可从无症状病例到盐皮质激素和/或雄激素过多的严重病例。目前,原发性全身性糖皮质激素抵抗仅与NR3C1基因缺陷有关。在此,我们报告一例青少年患者的病例,该患者经详细内分泌评估确诊为糖皮质激素抵抗,但NR3C1基因未发现确诊突变。